TITLE

Treatment patterns and clinical characteristics prior to initiating depot typical antipsychotics for nonadherent schizophrenia patients

PUB. DATE
January 2009
SOURCE
BMC Psychiatry;2009, Vol. 9, p46
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
44171281

 

Related Articles

  • Long-acting typical and atypical antipsychotics in treatment of schizophrenia: A retrospective comparison. Virit, Osman; Altindag, Abdurrahman; BuIbuI, Feridun; Savas, Haluk Asuman; Dalkilic, Alican // Klinik Psikofarmakoloji Bulteni;Jun2009, Vol. 19 Issue 2, p119 

    Objective: Long-acting antipsychotics were introduced to improve therapeutic outcomes in patients with schizophrenia experiencing sub-optimal improvement due to lack of or partial adherence to long-term treatment. Approximately 15% of schizophrenia patients in maintenance antipsychotic treatment...

  • Manage schizophrenia with individualized care. Boccuzzi, Stephen J. // Managed Healthcare Executive;Aug2012, Vol. 22 Issue 8, p13 

    The article focuses on the issues on the nonadherence of schizophrenia patients and the approach to overcome such issues. It states that nonadherent patients significantly contribute on mental healthcare cost as they are likely to have clinical relapse and hospitalization. It highlights the...

  • Relationships between Use of Long Acting Antipsychotics and Sociodemographic and Clinical Characteristics of Patients with Schizophrenia. Albayrak, Yakup; Unsal, Cuneyt; Beyazyuz, Murat // Klinik Psikofarmakoloji Bulteni;2013, Vol. 23 Issue 2, p171 

    Objective: Schizophrenia is a chronic psychiatric disorder that causes severe sociooccupational disability. The primary goal of treatment is to prevent a subsequent relapse and restore sociooccupational functioning to the premorbid level. However, high rates of relapses can be seen during the...

  • Relationships between Use of Long Acting Antipsychotics and Sociodemographic and Clinical Characteristics of Patients with Schizophrenia. Albayrak, Yakup; Unsal, Cuneyt; Beyazyuz, Murat // Klinik Psikofarmakoloji Bulteni;Jun2013, Vol. 23 Issue 2, p171 

    Objective: Schizophrenia is a chronic psychiatric disorder that causes severe sociooccupational disability. The primary goal of treatment is to prevent a subsequent relapse and restore sociooccupational functioning to the premorbid level. However, high rates of relapses can be seen during the...

  • Treatment of schizophrenia with antipsychotics in Norwegian emergency wards, a cross-sectional national study. Kroken, Rune A.; Johnsen, Erik; Ruud, Torleif; Wentzel-Larsen, Tore; Jørgensen, Hugo A // BMC Psychiatry;2009, Vol. 9, Special section p1 

    Background: Surveys on prescription patterns for antipsychotics in the Scandinavian public health system are scarce despite the prevalent use of these drugs. The clinical differences between antipsychotic drugs are mainly in the areas of safety and tolerability, and international guidelines for...

  • A New Psychosocial Tool for Gaining Patient Understanding and Acceptance of Long-acting Injectable Antipsychotic Therapy. Lasser, Robert A.; Schooler, Nina R.; Kujawa, Mary; Jarboe, Kathleen; Docherty, John; Weiden, Peter // Psychiatry (1550-5952);Apr2009, Vol. 6 Issue 4, p22 

    Nonadherence to antipsychotic medications in serious, persistent mental illness remains a significant clinical challenge. Long-acting therapy was developed to help improve adherence to schizophrenia therapy and provide an effective means for ameliorating symptoms and preventing relapse. The...

  • Long-Acting Injectable Antipsychotics for First-Episode Schizophrenia: The Pros and Cons. Kim, Borah; Lee, Sang-Hyuk; Yen Kuang Yang; Park, Jong-Il; Chung, Young-Chul // Schizophrenia Research & Treatment;2012, p1 

    Clinical and psychosocial deterioration associated with schizophrenia occurs within the first few years following the onset of the illness. Therefore, to improve the long-term prognosis, it is important to provide schizophrenia patients with intensive treatment following their first episode....

  • Early non-adherence to antipsychotics incurs higher costs.  // PharmacoEconomics & Outcomes News;4/1/2013, Issue 675, p7 

    An abstract of the article "Impact of Early Nonadherence to Oral Antipsychotics on Clinical and Economic Outcomes Among Patients with Schizophrenia," by S. Offord and colleagues is presented.

  • Non-adherence to antipsychotic medication, relapse and rehospitalisation in recent-onset schizophrenia. Morken, Gunnar; Widen, Jan H.; Grawe, Rolf W. // BMC Psychiatry;2008, Vol. 8, Special section p1 

    Background: The aims of this study were to describe outcome with respect to persistent psychotic symptoms, relapse of positive symptoms, hospital admissions, and application of treatment by coercion among patients with recent onset schizophrenia being adherent and nonadherent to anti-psychotic...

  • Long-acting Injectable Antipsychotics in First-episode Schizophrenia. Jeong, Hyun-Ghang; Lee, Moon-Soo // Clinical Psychopharmacology & Neuroscience;Apr2013, Vol. 11 Issue 1, p1 

    Antipsychotic medications are important for the successful management of schizophrenia. Continuous treatment with medication is superior in relapse prevention and non-adherence to antipsychotic medication is associated with a poor clinical outcome. Long-acting injectable antipsychotics (LAIs)...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics